Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 251

Results For "PLI"

3556 News Found

TaCa Healthcare expands its operations to Telangana and Andhra Pradesh
Healthcare | June 11, 2022

TaCa Healthcare expands its operations to Telangana and Andhra Pradesh

Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states


AIkido Pharma appoints Soo Yu as Director
People | June 11, 2022

AIkido Pharma appoints Soo Yu as Director

New Director supports NASDAQ rule on diversity


University of Glasgow opens Mazumdar Shaw Advance Research Centre
News | June 10, 2022

University of Glasgow opens Mazumdar Shaw Advance Research Centre

The £118 million Mazumdar-Shaw Advanced Research Centre (ARC) will be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.


Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus
Clinical Trials | June 10, 2022

Marinus expands enrollment criteria to support recruitment in Phase 3 RAISE Trial in refractory status epilepticus

Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.


India's bio-economy has grown 8 times in the last 8 years: PM Modi
Biotech | June 10, 2022

India's bio-economy has grown 8 times in the last 8 years: PM Modi

We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”


GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer
News | June 10, 2022

GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer

Healthcare is timely and personal – and its delivery should be too


Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod
News | June 08, 2022

Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod

Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis


India is dedicated to ensure health Security for every citizen: Mandaviya
Policy | June 08, 2022

India is dedicated to ensure health Security for every citizen: Mandaviya

States have an important role in ensuring food safety and healthy food practices.


CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox
Clinical Trials | June 08, 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit


Lupin receives tentative approval from FDA for Ivacaftor tablets
Drug Approval | June 08, 2022

Lupin receives tentative approval from FDA for Ivacaftor tablets

Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.